Bristol-Myers Squibb Co. (BMY) Stock Up 1.47%: Latest Performance Analysis

A share price of Bristol-Myers Squibb Co. [BMY] is currently trading at $41.48, up 1.47%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BMY shares have gain 0.95% over the last week, with a monthly amount drifted -5.01%, and not seem to […]

Bristol-Myers Squibb’s [NYSE: BMY] Breyanzi Receives FDA Approval

Bristol-Myers Squibb [NYSE: BMY] declared that FDA has awarded permission to the Breyanzi of the firm for the therapy of adult sufferers with relapsed or refractory large B-cell lymphoma. Breyazni is a CAR T cell Therapy. This therapy is a ray of hope for the victims experiencing relapsed or refractory large B-cell lymphoma. The authorization […]